Inactive Instrument

Tandem Diabetes Care Inc Stock Nasdaq

Equities

US8753721047

Medical Equipment, Supplies & Distribution

Sales 2024 * 845M Sales 2025 * 936M Capitalization 2.3B
Net income 2024 * -109M Net income 2025 * -67M EV / Sales 2024 * 2.53 x
Net cash position 2024 * 156M Net cash position 2025 * 122M EV / Sales 2025 * 2.32 x
P/E ratio 2024 *
-21.5 x
P/E ratio 2025 *
-34.7 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.36%
More Fundamentals * Assessed data
Dynamic Chart
North American Morning Briefing : Tech Still in -2- DJ
Leerink Partners Upgrades Tandem Diabetes Care to Outperform Rating, Price Target is $45 MT
Stifel Adjusts Price Target on Tandem Diabetes Care to $40 From $37, Maintains Buy Rating MT
North American Morning Briefing : Stocks Edge -2- DJ
Tandem Diabetes Care Shares Rise After Stifel Upgrade MT
Stifel Upgrades Tandem Diabetes Care to Buy From Hold, Adjusts Price Target to $37 From $24 MT
Citigroup Raises Price Target on Tandem Diabetes Care to $31 From $25, Keeps Neutral Rating MT
Transcript : Tandem Diabetes Care, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 03:35 PM
Transcript : Tandem Diabetes Care, Inc. Presents at Oppenheimer 34th Annual Healthcare MedTech & Services Conference 2024, Mar-12-2024 01:20 PM
Transcript : Tandem Diabetes Care, Inc. Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-06-2024 11:00 AM
Tandem Diabetes Care Shares Drop 12% After Private Placement for Senior Notes DJ
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday MT
Tandem Diabetes Care Plans $250 Million Private Placement Notes -- Shares Decline After Hours MT
Transcript : Tandem Diabetes Care, Inc. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 01:30 PM
Transcript : Tandem Diabetes Care, Inc. Presents at Citi?s 2024 Unplugged Medtech and Life Sciences Access Day, Feb-29-2024 01:00 PM
More news
Managers TitleAgeSince
Chief Executive Officer 68 13-02-28
Director of Finance/CFO 51 13-08-31
Compliance Officer 58 21-12-31
Members of the board TitleAgeSince
Chairman 64 19-01-02
Director/Board Member 64 13-06-30
Director/Board Member 71 07-08-31
More insiders
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Calendar
More about the company